IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MOTTA, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 707
EU - Europa 372
AS - Asia 152
AF - Africa 1
Totale 1.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 703
DE - Germania 140
CN - Cina 101
UA - Ucraina 77
GB - Regno Unito 51
FI - Finlandia 27
RU - Federazione Russa 27
HK - Hong Kong 24
IT - Italia 20
SG - Singapore 18
IE - Irlanda 12
CZ - Repubblica Ceca 7
FR - Francia 6
IN - India 5
CA - Canada 3
SE - Svezia 3
TR - Turchia 2
CI - Costa d'Avorio 1
KR - Corea 1
MS - Montserrat 1
NL - Olanda 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.232
Salva come PNG Salva come JPEG
Città #
Woodbridge 108
Fairfield 106
Houston 65
Jacksonville 60
Ann Arbor 50
Seattle 46
Ashburn 42
Cambridge 42
Chandler 28
Wilmington 25
Hong Kong 24
Princeton 24
New York 22
Lancaster 21
Nanjing 20
Helsinki 16
Beijing 14
Dublin 12
Hebei 11
Shenyang 9
Nanchang 7
San Diego 7
Singapore 7
Brno 6
Brescia 5
Changsha 5
Dearborn 5
Des Moines 5
Nürnberg 5
Jinan 4
Shanghai 4
Tianjin 4
Kunming 3
Milan 3
Zhengzhou 3
Changchun 2
Hangzhou 2
Jiaxing 2
Kocaeli 2
Ningbo 2
Toronto 2
Abidjan 1
Amsterdam 1
Boardman 1
Carhaix 1
Cleveland 1
Fremont 1
Fuzhou 1
Guangzhou 1
Haikou 1
London 1
Monmouth Junction 1
Montreal 1
Munich 1
North Bergen 1
Norwalk 1
Olomouc 1
San Francisco 1
San Mateo 1
Scottsdale 1
Seoul 1
Taipei 1
Taiyuan 1
Taizhou 1
Verona 1
Villanuova Sul Clisi 1
Warsaw 1
Totale 856
Salva come PNG Salva come JPEG
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 190
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 143
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 135
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 120
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 109
Virological effectiveness and CD4+ T-cell increase over early andlate courses in HIV infected patients on antiretroviral therapy: focus on HCV andanchor class received 104
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 96
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. 94
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 91
Elderly women with human immunodeficiency virus infection: is there an effect of the virus on neuropsychological prolife? 78
The neuropsychological effects of aging with HIV infection in elderly women 58
Unboosted Atazanavir for Treatment ofHIV Infection: Rationale and Recommendations for Use 56
Totale 1.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020358 52 13 16 46 22 34 36 40 28 48 7 16
2020/2021165 4 23 3 18 4 27 7 16 23 20 16 4
2021/2022111 7 25 0 7 1 1 5 3 6 13 9 34
2022/202381 12 1 1 4 9 26 0 5 18 1 1 3
2023/2024106 5 3 5 10 2 23 7 4 25 1 1 20
Totale 1.274